| Term 
 
        | Lente or L-type; describe, use, blockers |  | Definition 
 
        | slow channels for supraventricular arrhythmias
 Verapamil, diltiazem, nifedipine
 |  | 
        |  | 
        
        | Term 
 
        | Transient or T-type; describe, use, blockers |  | Definition 
 
        | fast channels (only open briefly) anti-seizure meds
 ethosuximide, methsuximide, zonisamide, valproylamide, phenytoin
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Decrease NT release for chronic pain
 Gabapentin and pregabalin
 |  | 
        |  | 
        
        | Term 
 
        | verapamil; type? action? use? SEs? |  | Definition 
 
        | non-selective (cardiac vs. vascular) L-type CaCB decreases HR and O2 Uses - supraventricular arrhythmia SEs - constipation, edema, increased digoxin levels |  | 
        |  | 
        
        | Term 
 
        | Nifedipine; type? action? T1/2? |  | Definition 
 
        | vascular L-type CaCB lower blood pressure arteriole vasodilator - decreases afterload 3-4hr, halflife |  | 
        |  | 
        
        | Term 
 
        | Diltiazem; type? action? use? |  | Definition 
 
        | L-type CaCB Decreases HR and 02 demand
 Use - coronary artery vasospasm
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | T-type CaCB Use - absanes petite mal seizures
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | T-type CaCB use - absence (petit mal) seizures
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | T-type CaCB Mixed mode of action (MOA) drug
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | T-type CaCB anti-seizure Mixed mode of action (MOA) drug |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | T-type CaCB (NaCB and CaCB) anti-seizure med CYP 3A4 inducer SEs - gum hyperplasia, Hirsuitism, folate deficiency, megaloblastic anemia, rash, peripheral neuropathy |  | 
        |  | 
        
        | Term 
 
        | pregabalin and gabapentin |  | Definition 
 
        | N-type/NPQR reduce NT release
 use - chronic pain
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Ryanodine Receptor blocker inhibits release of intracellular Ca from skeletal muscle sarcoplasmic reticulum
 use- malignant hyperthermia
 |  | 
        |  |